GLP-1: Barclays on why 2025 could be an inflection point

Investing.com — The landscape of GLP-1 drugs, which are widely recognized for their efficacy in weight loss and diabetes management, is poised for a potential transformation in 2025, as per…
Input your search keywords and press Enter.